APA (7th ed.) Citation

Sumit Saxena, Manu Chaudhary, Saransh Chaudhary, & Anmol Aggarwal. (2022). Bioequivalence of a biosimilar enoxaparin (Cloti‐Xa™) and its innovator (Clexane®): A single‐dose, randomized, double‐blind, two‐period, two‐treatment, two‐sequence, crossover, balanced study in healthy human subjects. Wiley.

Chicago Style (17th ed.) Citation

Sumit Saxena, Manu Chaudhary, Saransh Chaudhary, and Anmol Aggarwal. Bioequivalence of a Biosimilar Enoxaparin (Cloti‐Xa™) and Its Innovator (Clexane®): A Single‐dose, Randomized, Double‐blind, Two‐period, Two‐treatment, Two‐sequence, Crossover, Balanced Study in Healthy Human Subjects. Wiley, 2022.

MLA (9th ed.) Citation

Sumit Saxena, et al. Bioequivalence of a Biosimilar Enoxaparin (Cloti‐Xa™) and Its Innovator (Clexane®): A Single‐dose, Randomized, Double‐blind, Two‐period, Two‐treatment, Two‐sequence, Crossover, Balanced Study in Healthy Human Subjects. Wiley, 2022.